NRP1 and pancreatic adenocarcinoma: In the log-rank test, the overall survival (OS) results revealed that NRP1 acts as a risk factor for patients with CSEC, LIHC, LUSC, PAAD, SARC and STAD, and as a protective factor in patients with KIRC.